Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer

Multiple randomized studies have shown that combination of chemotherapy and immune checkpoint inhibitors (ICIs) leads to better response rates and survival as compared to chemotherapy alone in the advanced stage of NSCLC. Data suggesting a benefit to using ICIs in the neoadjuvant therapy of patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Tfayli, Arafat, Al Assaad, Majd, Fakhri, Ghina, Akel, Reem, Atwi, Hanine, Ghanem, Hady, El Karak, Fadi, Farhat, Fadi, Al Rabi, Kamal, Sfeir, Pierre, Youssef, Pierre, Mansour, Ziad, Assi, Hazem, Haidar, Mohamad, Abi Ghanem, Alain, Khalifeh, Ibrahim, Boulos, Fouad, Mahfouz, Ramy, Youssef, Bassem, Zeidan, Youssef, Bejjany, Rachelle, Khuri, Fadlo
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7666740/
https://ncbi.nlm.nih.gov/pubmed/32991781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3456
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados